Now showing items 1-10 of 10

    • Abuse of Dominance by High-Technology Enterprises: A Comparison of U.S. and E.C. Approaches 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2010)
      This paper compares how the United States and the European Community dealt with competition policy challenges by two firms operating at the frontiers of technology: Microsoft and Intel. The U.S. Microsoft case was broadly ...
    • The Dynamics of Capitalism 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2010)
      This paper, written for a larger compendium edited by Dennis Mueller, examines key dynamic features of capitalistic economies and how prominent economists such as Schumpeter, Marx, Keynes, and von Mises perceived them. The ...
    • Financial Mergers and Their Consequences 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2012)
      This paper, written for a Columbia Law School - American Bar Association conference, analyzes the massive merger wave that has led to substantially increased concentration of banking activity in the United States. One ...
    • General Hamilton and Dr. Smith 

      Scherer, Frederic Michael (John F. Kennedy School of Government, 2012)
      In 1791 Alexander Hamilton submitted as U.S. Secretary of the Treasury a now-famous Report on the Subject of Manufactures. In it he criticized arguments that the U.S. colonies should remain preponderantly agricultural. He ...
    • Merger Efficiencies and Competition Policy 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2012)
      Since the United States changed its guidelines in 1984, many industrialized nations have included efficiencies defenses in their rules for judging whether mergers and other activities that might lessen competition are on ...
    • Mergers and Innovation in the Pharmaceutical Market 

      Comanor, William S.; Scherer, Frederic Michael (John F.Kennedy School of Government, Harvard University., 2011)
      The U.S. pharmaceutical industry has experienced in recent years two dramatic changes: stagnation in the growth of new molecular entities approved for marketing, and a wave of mergers linking inter alia some of the largest ...
    • Parallel R&D Paths Revisited 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2011)
      This paper revisits the logic of pursuing parallel R&D paths when there is uncertainty as to which approaches will succeed technically and/or economically. Previous findings by Richard Nelson and the present author are ...
    • A Perplexed Economist Confronts 'Too Big to Fail' 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2010)
      This paper, written for a conference at the Fordham University Law School, examines various facets of the “too big to fail” debate. It notes that in the current context, “too big to fail” may imply systemic risks from large ...
    • R&D Costs and Productivity in Biopharmaceuticals 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2011)
      This article characterizes the activities required to launch a new pharmaceutical molecule into the market, summarizes studies that have attempted to pinpoint the research and development costs incurred per approved new ...
    • Standard Oil as a Technological Innovator 

      Scherer, Frederic Michael (John F. Kennedy School of Government, Harvard University, 2011)
      A century ago, in 1911, the U.S. Supreme Court issued its path-breaking decision in the monopolization case against the Standard Oil Companies. Standard pleaded inter alia that its near-monopoly position was the result of ...